282 related articles for article (PubMed ID: 9043838)
1. The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).
Bestehorn HP; Rensing UF; Roskamm H; Betz P; Benesch L; Schemeitat K; Blümchen G; Claus J; Mathes P; Kappenberger L; Wieland H; Neiss A
Eur Heart J; 1997 Feb; 18(2):226-34. PubMed ID: 9043838
[TBL] [Abstract][Full Text] [Related]
2. [Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS].
Rensing UF; Bestehorn HP; Roskamm H; Petersen J; Betz P; Spinder M; Benesch L; Schemeitat K; Blümchen G; Claus J; Wieland H; Böcker JF; Neiss A; Stiepel E; Mathes P; Kappenberger L; Braunagel K; Peters K; Meister G; Samek L; Schuon J; Leimenstoll B; Kiefer H
Z Kardiol; 1999 Apr; 88(4):270-82. PubMed ID: 10408031
[TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS).
Lancet; 1994 Sep; 344(8923):633-8. PubMed ID: 7864934
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
Hunninghake DB
Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
7. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
Lintott CJ; Scott RS; Sutherland WH; Bremer J
Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151
[TBL] [Abstract][Full Text] [Related]
8. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Kroon AA; van Asten WN; Stalenhoef AF
Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
[TBL] [Abstract][Full Text] [Related]
9. Lipid control with low-dosage simvastatin in patients with moderate hypercholesterolaemia. An Italian multicentre double-blind placebo-controlled study.
Capurso A; Resta F; Bertolini S; Masturzo P; Feruglio FS; Cattin L; Da Col PG; Descovich GC; Gaddi A; Urbinati GC
Eur Heart J; 1992 Jul; 13 Suppl B():11-6. PubMed ID: 1644094
[No Abstract] [Full Text] [Related]
10. A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study.
Mizuno K; Nakamura H; Ohashi Y; Kaburagi T; Kitabatake A; Tochihara T; Hosoda S;
Clin Ther; 2004 Jun; 26(6):878-88. PubMed ID: 15262458
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
12. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
Bach LA; Cooper ME; O'Brien RC; Jerums G
J Am Geriatr Soc; 1990 Jan; 38(1):10-4. PubMed ID: 2404052
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.
Plosker GL; McTavish D
Drugs; 1995 Aug; 50(2):334-63. PubMed ID: 8521762
[TBL] [Abstract][Full Text] [Related]
14. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
Post Coronary Artery Bypass Graft Trial Investigators
N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
[TBL] [Abstract][Full Text] [Related]
15. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Simons LA; Simons J; Parfitt A
Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
[TBL] [Abstract][Full Text] [Related]
16. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis.
Kroon AA; Aengevaeren WR; van der Werf T; Uijen GJ; Reiber JH; Bruschke AV; Stalenhoef AF
Circulation; 1996 May; 93(10):1826-35. PubMed ID: 8635262
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
[TBL] [Abstract][Full Text] [Related]
18. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria.
Thomas ME; Harris KP; Ramaswamy C; Hattersley JM; Wheeler DC; Varghese Z; Williams JD; Walls J; Moorhead JF
Kidney Int; 1993 Nov; 44(5):1124-9. PubMed ID: 8264145
[TBL] [Abstract][Full Text] [Related]
20. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
Keech A; Collins R; MacMahon S; Armitage J; Lawson A; Wallendszus K; Fatemian M; Kearney E; Lyon V; Mindell J
Eur Heart J; 1994 Feb; 15(2):255-69. PubMed ID: 8005129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]